Clinical Trials Directory

Trials / Completed

CompletedNCT04629989

Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will compare the impact of two systems above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19. The two systems are the Surgical Mask (SM) and the Double-Trunk Mask (DTM).

Detailed description

Hospitalized patients with COVID-19 typically present with hypoxemia. In some patients, hypoxemia can be corrected with low flow nasal cannula. When placed above nasal cannula, some systems have demonstrated their interest in improving the performance of patient's oxygen delivery. For example, two recent studies have shown that adding a Double-Trunk Mask (DTM) or Surgical Mask (SM) above nasal cannula has the potential to improve the PaO2 despite no change in oxygen output (Duprez et al., J Clin Monit Comput 2020; Montiel et al., Ann Intensive Care 2020). However, there is no study comparing the relative effectiveness of these 2 systems.

Conditions

Interventions

TypeNameDescription
OTHERStandard Oxygen Delivery SystemThe standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
OTHERDouble-Trunk MaskThe Double-Trunk Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
OTHERSurgical MaskThe Surgical Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.

Timeline

Start date
2020-11-13
Primary completion
2021-03-05
Completion
2021-03-05
First posted
2020-11-16
Last updated
2021-03-09

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04629989. Inclusion in this directory is not an endorsement.